The role of Campylobacter (Helicobacter) pylori in disorders of the gastrointestinal tract Barbara PrzyklenkA. BauernfeindK. Heilmann Originalia Pages: 3 - 7
Prevalence of antibodies to human herpesvirus 6 in different age groups, in children with exanthema subitum, other acute exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other herpesviruses and HIV Gisela EndersMarion BiberElke Helftenbein Originalia Pages: 12 - 15
Cefotaxime versus penicillin in the late stage of lyme disease — prospective, randomized therapeutic study D. HasslerL. ZöllerF. Heinrich Originalia Pages: 16 - 20
Epidemiology of chronic viral hepatitis in the mediterranean area: Present status and trends G. B. GaetaG. Giusti Review Pages: 21 - 25
A study on delta virus infection and its clinical impact in Iran H. RezvanS. TaroyanF. Azordegan Originalia Pages: 26 - 28
Haematogenous Serratia marcescens endophthalmitis in an HIV-infected intravenous drug addict R. AlvarezJ. A. MartinezA. Casale Case Report Pages: 29 - 30
Legionella longbeachae pneumonia in a patient splenectomized for hairy-cell leukemia Ruth LangZ. WilerIda Boldur Case Report Pages: 31 - 32
Unusual manifestations of Epstein-Barr Virus encephalomyelitis R. R. McKendallS. A. SadiqJ. R. Calverley Case Report Pages: 33 - 35
Chemiluminescence response of human polymorphonuclear and mononuclear phagocytic cells induced by Staphylococcus saprophyticus, lectinophagocytosis versus opsonophagocytosis J. BeuthH. L. KoP. Quie Originalia Pages: 36 - 39
Co-trimoxazole for visceral leishmaniasis A. Rodriguez-CuarteroF. J. Pérez-BlancoA. López-Fernández Letter To The Editor Pages: 40 - 40
Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of β-lactamases D. H. WittmannA. P. WalkerJ. Oleszkiewicz Addendum I Pages: 41 - 47
Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins A. Bauernfeind Addendum II Pages: 48 - 52
Clinical significance of Staphylococcus aureus in cystic fibrosis M. I. Marks Addendum III Pages: 53 - 56
Staphylococcus aureus in patients with cystic fibrosis: An epidemiological analysis using a combination of traditional and molecular methods R. V. GoeringA. BauernfeindW. Lenz Addendum III Pages: 57 - 60
The role of bacterial adhesion in cystic fibrosis including the Staphylococcal aspect R. Ramphal Addendum III Pages: 61 - 64